FDA Clearance Tracker · P100010-S046
ARCTIC FRONT ADVANCE CARDIAC CRYOABLATION CATHETER
Last checked: Nov 20, 2026Latest source record: Feb 27, 2015 (this decision)Source: openFDAMethods & limitations
Decided
Feb 27, 2015
Approved
Time to decision
81 days
Received Dec 8, 2014. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P100010-S046
- Device name
- ARCTIC FRONT ADVANCE CARDIAC CRYOABLATION CATHETER
- Applicant
- Medtronic Cryocath, LP
- Applicant location
- Mounds View, MN
- Received
- Dec 8, 2014
- Decided
- Feb 27, 2015
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P100010
Device type
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR TWO NEW MODELS TO BE ADDED TO THE ARCTIC FRONT FAMILY OF CARDIAC CRYOABLATION CATHETERS: ARCTIC FRONT ADVANCE ST CARDIAC CRYOABLATION CATHETERS MODELS 2AFAST23 AND 2AFAST28.
Source documents
Other decisions for Medtronic Cryocath, LP
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P100010-S110 · Decided Jun 18, 2021 · 231 days after receipt · Panel Track
Device type: Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation (OAE) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.